EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of prognostic value of vascular endothelial growth factor and endocan in non-small cell lung cancer

Mesut Melih Özercan iD, Burcu Ancin iD, Yiğit Yilmaz iD, Ahmet Müderrisoğlu iD, Serkan Uysal iD, Ulaş Kumbasar iD, Zeynep Saribaş iD, Erkan Dikmen iD, Rıza Doğan iD

Turkish Journal of Medical Sciences · 12.12.2025 · 55 (6) · 1424-1434

DOI: 10.55730/1300-0144.6100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 12.12.2025. Verfasst von Mesut Melih Özercan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkiye. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Proteoglycans, Vascular Endothelial Growth Factor A, Lung Neoplasms. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: No reliable, easily measurable biomarker currently exists for the screening or prognosis of lung cancer. The present study evaluates the potential utility of vascular endothelial growth factor (VEGF) and endocan, which can be readily measured in blood samples, as biomarkers for screening and prognostic assessment in lung cancer. Materials and methods: Included in the study were 38 patients with early-stage non-small cell lung cancer (NSCLC) and 29 controls. All patients underwent surgical intervention and were monitored for 1 month postoperatively. Serum VEGF and endocan levels were measured preoperatively and postoperatively. Clinical characteristics, laboratory data, and histopathological findings were recorded for all participants.

Results

The preoperative VEGF levels of the patients were significantly higher than those of the controls (p = 0.001), while postoperative VEGF levels decreased significantly following surgery (p < 0.001). The endocan levels of the patients and controls were similar preoperatively. Additionally, endocan levels were significantly increased after the surgery in the patient group (p < 0.001). A comparison of VEGF and endocan levels according to TNM staging and tumor histopathology revealed no significant differences.

Conclusion

VEGF can serve as a potential biomarker for screening and prognostic assessment in early-stage NSCLC. In contrast, endocan did not demonstrate utility for such clinical purposes. VEGF may also be considered for the evaluation of treatment efficacy following surgical intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungProteoglycansVascular Endothelial Growth Factor ALung NeoplasmsNeoplasm ProteinsBiomarkers, TumorHumansFemaleMalePrognosisMiddle AgedAged

Stichwörter der Autor:innen

EndocanVEGFnon-small cell lung cancerprognosisscreening

Substanzen

ProteoglycansESM1 protein, humanVascular Endothelial Growth Factor ANeoplasm ProteinsBiomarkers, TumorVEGFA protein, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkiye.
  • Department of Thoracic Surgery, Burdur State Hospital, Burdur, Turkiye.
  • Department of Thoracic Surgery, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
  • Department of Pharmacology, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkiye.
  • Department of Medical Microbiology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.
  • Emeritus, Department of Thoracic Surgery, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.

ORCID-Profile: Mesut Melih Özercan, Burcu Ancin, Yiğit Yilmaz, Ahmet Müderrisoğlu, Serkan Uysal, Ulaş Kumbasar, Zeynep Saribaş, Erkan Dikmen, Rıza Doğan

Zitieren

APA

Özercan, M. M., Ancin, B., Yilmaz, Y., Müderrisoğlu, A., Uysal, S., Kumbasar, U., Saribaş, Z., Dikmen, E., & Doğan, R. (2025). Evaluation of prognostic value of vascular endothelial growth factor and endocan in non-small cell lung cancer. Turkish Journal of Medical Sciences, 55(6), 1424-1434. https://doi.org/10.55730/1300-0144.6100

Vancouver

Özercan MM, Ancin B, Yilmaz Y, Müderrisoğlu A, Uysal S, Kumbasar U, et al. Evaluation of prognostic value of vascular endothelial growth factor and endocan in non-small cell lung cancer. Turkish Journal of Medical Sciences. 2025;55(6):1424-1434. doi:10.55730/1300-0144.6100

BibTeX
@article{zercan2025,
  author = {Özercan, Mesut Melih and Ancin, Burcu and Yilmaz, Yiğit and Müderrisoğlu, Ahmet and Uysal, Serkan and Kumbasar, Ulaş and Saribaş, Zeynep and Dikmen, Erkan and Doğan, Rıza},
  title = {Evaluation of prognostic value of vascular endothelial growth factor and endocan in non-small cell lung cancer},
  journal = {Turkish Journal of Medical Sciences},
  year = {2025},
  volume = {55},
  number = {6},
  pages = {1424--1434},
  doi = {10.55730/1300-0144.6100}
}
Kostenlos starten →